Comparative Efficacy of Mayaro Virus-Like Particle Vaccines Produced in Insect or Mammalian Cells
Sandra R. Abbo, Wilson Nguyen, Marleen H. C. Abma-Henkens, Denise van de Kamer, Niek H. A. Savelkoul, Corinne Geertsema, Thuy T. Le, Bing Tang, Kexin Yan, Troy Dumenil, Monique M. van Oers, Andreas Suhrbier, Gorben P. Pijlman
Abstract
Mayaro virus (MAYV) is associated with acute rheumatic disease that can be debilitating and can evolve into months of chronic arthralgia. MAYV is believed to have the potential to emerge as a tropical public health threat, especially if it develops the ability to be efficiently transmitted by urban mosquito vectors, such as Aedes aegypti and/or Aedes albopictus. Here, we describe a scalable virus-like particle vaccine against MAYV that induced neutralizing antibodies against a historical and a contemporary isolate of MAYV and protected mice against infection and disease, providing a potential new intervention for MAYV epidemic preparedness.